BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Jan 16, 15:50Prev. Close
92.71
Open Price
92.71
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Par Drugs & Chemicals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 7.75 | 5.40 | 5.54 | 6.84 | 2.71 | |
| Diluted EPS (Rs.) | 7.75 | 5.40 | 5.54 | 6.84 | 2.71 | |
| Cash EPS (Rs.) | 12.23 | 12.18 | 17.15 | 17.29 | 12.53 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 66.02 | 64.99 | 55.37 | 49.83 | 44.42 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 66.02 | 64.99 | 55.37 | 49.83 | 44.42 | |
| Dividend / Share(Rs.) | 1.25 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 90.78 | 103.39 | 156.95 | 180.61 | 123.20 | |
| PBDIT/Share (Rs.) | 15.52 | 18.49 | 29.71 | 31.50 | 27.65 | |
| PBIT/Share (Rs.) | 11.03 | 11.71 | 18.09 | 21.05 | 17.83 | |
| PBT/Share (Rs.) | 9.74 | 7.33 | 9.46 | 11.79 | 4.86 | |
| Net Profit/Share (Rs.) | 7.75 | 5.40 | 5.54 | 6.84 | 2.71 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 17.09 | 17.88 | 18.92 | 17.43 | 22.44 | |
| PBIT Margin (%) | 12.15 | 11.32 | 11.52 | 11.65 | 14.47 | |
| PBT Margin (%) | 10.72 | 7.08 | 6.02 | 6.52 | 3.94 | |
| Net Profit Margin (%) | 8.53 | 5.22 | 3.52 | 3.78 | 2.20 | |
| Return on Networth / Equity (%) | 11.73 | 8.30 | 10.00 | 13.73 | 6.10 | |
| Return on Capital Employed (%) | 13.77 | 13.48 | 13.10 | 15.59 | 13.54 | |
| Return on Assets (%) | 7.92 | 4.70 | 2.77 | 3.29 | 1.26 | |
| Total Debt/Equity (X) | 0.11 | 0.36 | 1.21 | 1.55 | 2.15 | |
| Asset Turnover Ratio (%) | 92.90 | 90.20 | 78.56 | 87.01 | 57.24 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.23 | 1.14 | 0.84 | 0.69 | 0.66 | |
| Quick Ratio (X) | 1.96 | 0.79 | 0.60 | 0.49 | 0.41 | |
| Inventory Turnover Ratio (X) | 19.15 | 10.79 | 10.42 | 12.23 | 5.96 | |
| Dividend Payout Ratio (NP) (%) | 32.27 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 20.43 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 67.73 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 79.57 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 16.62 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 1.74 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 67.72 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.35 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 |
27.11.2025
Par Drugs Standalone September 2025 Net Sales at Rs 28.66 crore, down 17.31% Y-o-Y
22.08.2025
Par Drugs Standalone June 2025 Net Sales at Rs 26.05 crore, up 15.22% Y-o-Y
12.05.2025
Par Drugs Standalone March 2025 Net Sales at Rs 22.33 crore, down 2.14% Y-o-Y
23.10.2024
Par Drugs Standalone September 2024 Net Sales at Rs 34.66 crore, up 33.88% Y-o-Y
15.03.2018
24.04.2017
24.04.2017
20.04.2017